{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T10:23:11Z","timestamp":1790677391932,"version":"4.1.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,3,16]],"date-time":"2019-03-16T00:00:00Z","timestamp":1552694400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1007\/s12325-019-00926-5","type":"journal-article","created":{"date-parts":[[2019,3,16]],"date-time":"2019-03-16T20:03:43Z","timestamp":1552766623000},"page":"1177-1189","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Assessing the Role of Anti rh-GAA in Modulating Response to ERT in a Late-Onset Pompe Disease Cohort from the Italian GSDII Study Group"],"prefix":"10.1007","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2852-7512","authenticated-orcid":false,"given":"Massimiliano","family":"Filosto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Cotti Piccinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Ravaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serenella","family":"Servidei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Moggio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olimpia","family":"Musumeci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Alice","family":"Donati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Pegoraro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Di Muzio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Maggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Tonin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianni","family":"Marrosu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Sancricca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Lerario","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Sacchini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Semplicini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"Bozzoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Telese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Bonanno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachele","family":"Piras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Antonietta","family":"Maioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Ricci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liliana","family":"Vercelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Galvagni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Gallo Cassarino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filomena","family":"Caria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiziana","family":"Mongini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Siciliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Padovani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Toscano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,16]]},"reference":[{"key":"926_CR1","doi-asserted-by":"publisher","first-page":"971","DOI":"10.2174\/1566524014666141010131649","volume":"14","author":"M Filosto","year":"2014","unstructured":"Filosto M, Cotelli MS, Vielmi V, et al. Late-onset glycogen storage disease type 2. Curr Mol Med. 2014;14:971\u20138. \n                    https:\/\/doi.org\/10.2174\/1566524014666141010131649\n                    \n                  .","journal-title":"Curr Mol Med"},{"key":"926_CR2","volume-title":"GeneReviews\u00ae","author":"N Leslie","year":"2007","unstructured":"Leslie N, Bailey L. Pompe disease. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews\u00ae. Seattle: University of Washington; 2007 (Internet, 1993\u20132018. Aug 31, updated 2017 May 11)."},{"key":"926_CR3","first-page":"91","volume":"32","author":"M Filosto","year":"2013","unstructured":"Filosto M, Todeschini A, Cotelli MS, et al. Non-muscle involvement in late-onset glycogenosis II. Acta Myol. 2013;32:91\u20134.","journal-title":"Acta Myol"},{"key":"926_CR4","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1210\/jc.2014-2763","volume":"100","author":"F Bertoldo","year":"2015","unstructured":"Bertoldo F, Zappini F, Brigo M, et al. Prevalence of asymptomatic vertebral fractures in late-onset Pompe disease. J Clin Endocrinol Metab. 2015;100:401\u20136. \n                    https:\/\/doi.org\/10.1210\/jc.2014-2763\n                    \n                  .","journal-title":"J Clin Endocrinol Metab"},{"key":"926_CR5","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1002\/mus.23533","volume":"47","author":"MS Cotelli","year":"2013","unstructured":"Cotelli MS, Todeschini A, Vielmi V, Seddio C, Padovani A, Filosto M. Hemangioma of the semimembranosus muscle in a patient with late-onset glycogenosis II. Muscle Nerve. 2013;47:142\u20133. \n                    https:\/\/doi.org\/10.1002\/mus.23533\n                    \n                  .","journal-title":"Muscle Nerve"},{"key":"926_CR6","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1007\/s10545-013-9601-7","volume":"36","author":"B Borroni","year":"2013","unstructured":"Borroni B, Cotelli MS, Premi E, et al. The brain in late-onset glycogenosis II: a structural and functional MRI study. J Inherit Metab Dis. 2013;36:989\u201395. \n                    https:\/\/doi.org\/10.1007\/s10545-013-9601-7\n                    \n                  .","journal-title":"J Inherit Metab Dis"},{"key":"926_CR7","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s10545-015-9913-x","volume":"39","author":"F Montagnese","year":"2016","unstructured":"Montagnese F, Granata F, Musumeci O, et al. Intracranial arterial abnormalities in patients with late onset Pompe disease (LOPD). J Inherit Metab Dis. 2016;39:391\u20138. \n                    https:\/\/doi.org\/10.1007\/s10545-015-9913-x\n                    \n                  .","journal-title":"J Inherit Metab Dis"},{"key":"926_CR8","doi-asserted-by":"publisher","DOI":"10.1111\/ene.13835","author":"O Musumeci","year":"2018","unstructured":"Musumeci O, Marino S, Granata F, et al. Central nervous system involvement in late-onset Pompe disease: clues from neuroimaging and neuropsychological analysis. Eur J Neurol. 2018. \n                    https:\/\/doi.org\/10.1111\/ene.13835\n                    \n                  .","journal-title":"Eur J Neurol"},{"key":"926_CR9","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1007\/s00415-012-6636-x","volume":"260","author":"A Toscano","year":"2013","unstructured":"Toscano A, Schoser B. Enzyme replacement therapy in late-onset Pompe disease: a systematic literature review. J Neurol. 2013;260:951\u20139. \n                    https:\/\/doi.org\/10.1007\/s00415-012-6636-x\n                    \n                  .","journal-title":"J Neurol"},{"key":"926_CR10","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1007\/s00415-016-8219-8","volume":"264","author":"B Schoser","year":"2017","unstructured":"Schoser B, Stewart A, Kanters S, et al. Survival and long-term outcomes in late-onset Pompe disease following alglucosidase alfa treatment: a systematic review and meta-analysis. J Neurol. 2017;264:621\u201330. \n                    https:\/\/doi.org\/10.1007\/s00415-016-8219-8\n                    \n                  .","journal-title":"J Neurol"},{"key":"926_CR11","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1056\/NEJMoa0909859","volume":"362","author":"AT Ploeg van der","year":"2010","unstructured":"van der Ploeg AT, Clemens PR, Corzo D, et al. A randomized study of alglucosidase alfa in late-onset Pompe\u2019s disease. N Engl J Med. 2010;362:1396\u2013406. \n                    https:\/\/doi.org\/10.1056\/NEJMoa0909859\n                    \n                  .","journal-title":"N Engl J Med"},{"key":"926_CR12","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1007\/s00415-011-6293-5","volume":"259","author":"C Angelini","year":"2012","unstructured":"Angelini C, Semplicini C, Ravaglia S, et al. Observational clinical study in juvenile-adult glycogenosis type 2 patients undergoing enzyme replacement therapy for up to 4 years. J Neurol. 2012;259:952\u20138. \n                    https:\/\/doi.org\/10.1007\/s00415-011-6293-6295\n                    \n                  .","journal-title":"J Neurol"},{"key":"926_CR13","doi-asserted-by":"publisher","first-page":"2365","DOI":"10.1212\/WNL.0000000000004711","volume":"89","author":"E Kuperus","year":"2017","unstructured":"Kuperus E, Kruijshaar ME, Wens SCA, et al. Long-term benefit of enzyme replacement therapy in Pompe disease: a 5-year prospective study. Neurology. 2017;89:2365\u201373. \n                    https:\/\/doi.org\/10.1212\/WNL.0000000000004711\n                    \n                  .","journal-title":"Neurology"},{"key":"926_CR14","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s13023-014-0102-z","volume":"9","author":"P Filippi De","year":"2014","unstructured":"De Filippi P, Saeidi K, Ravaglia S, et al. Genotype-phenotype correlation in Pompe disease, a step forward. Orphanet J Rare Dis. 2014;9:102. \n                    https:\/\/doi.org\/10.1186\/s13023-014-0102-z\n                    \n                  .","journal-title":"Orphanet J Rare Dis"},{"key":"926_CR15","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.ymgme.2010.08.009","volume":"101","author":"JM Vries de","year":"2010","unstructured":"de Vries JM, van der Beek NA, Kroos MA, et al. High antibody titer in an adult with Pompe disease affects treatment with alglucosidase alfa. Mol Genet Metab. 2010;101:338\u201345. \n                    https:\/\/doi.org\/10.1016\/j.ymgme.2010.08.009\n                    \n                  .","journal-title":"Mol Genet Metab"},{"key":"926_CR16","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.ymgme.2012.04.027","volume":"106","author":"TT Patel","year":"2012","unstructured":"Patel TT, Banugaria SG, Case LE, Wenninger S, Schoser B, Kishnani PS. The impact of antibodies in late-onset Pompe disease: a case series and literature review. Mol Genet Metab. 2012;106:301\u20139. \n                    https:\/\/doi.org\/10.1016\/j.ymgme.2012.04.027\n                    \n                  .","journal-title":"Mol Genet Metab"},{"key":"926_CR17","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/gim.2016.70","volume":"19","author":"JM Vries de","year":"2017","unstructured":"de Vries JM, Kuperus E, Hoogeveen-Westerveld M, et al. Pompe disease in adulthood: effects of antibody formation on enzyme replacement therapy. Genet Med. 2017;19:90\u20137. \n                    https:\/\/doi.org\/10.1038\/gim.2016.70\n                    \n                  .","journal-title":"Genet Med"},{"key":"926_CR18","doi-asserted-by":"publisher","first-page":"36182","DOI":"10.1038\/srep36182","volume":"6","author":"E Masat","year":"2016","unstructured":"Masat E, Lafor\u00eat P, De Antonio M, et al. Long-term exposure to Myozyme results in a decrease of anti-drug antibodies in late-onset Pompe disease patients. Sci Rep. 2016;6:36182. \n                    https:\/\/doi.org\/10.1038\/srep36182\n                    \n                  .","journal-title":"Sci Rep"},{"key":"926_CR19","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.nmd.2015.04.006","volume":"25","author":"B Schoser","year":"2015","unstructured":"Schoser B, Lafor\u00eat P, Kruijshaar ME, Toscano A, van Doorn PA, van der Ploeg AT, European Pompe Consortium (EPOC). 208th ENMC international workshop: formation of a European network to develop a European data sharing model and treatment guidelines for Pompe disease Naarden, The Netherlands, 26\u201328 September 2014. Neuromuscul Disord. 2015;25:674. \n                    https:\/\/doi.org\/10.1016\/j.nmd.2015.04.006\n                    \n                  .","journal-title":"Neuromuscul Disord"},{"key":"926_CR20","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13023-018-0771-0","volume":"13","author":"R Parini","year":"2018","unstructured":"Parini R, De Lorenzo P, Dardis A, et al. Long term clinical history of an Italian cohort of infantile onset Pompe disease treated with enzyme replacement therapy. Orphanet J Rare Dis. 2018;13:32. \n                    https:\/\/doi.org\/10.1186\/s13023-018-0771-0\n                    \n                  .","journal-title":"Orphanet J Rare Dis"},{"key":"926_CR21","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.ymgmr.2016.07.005","volume":"8","author":"RC Baek","year":"2016","unstructured":"Baek RC, Palmer R, Pomponio RJ, et al. The influence of a polymorphism in the gene encoding angiotensin converting enzyme (ACE) on treatment outcomes in late-onset Pompe patients receiving alglucosidase alfa. Mol Genet Metab Rep. 2016;8:48\u201350. \n                    https:\/\/doi.org\/10.1016\/j.ymgmr.2016.07.005\n                    \n                  .","journal-title":"Mol Genet Metab Rep"},{"key":"926_CR22","first-page":"141","volume":"34","author":"B Schoser","year":"2015","unstructured":"Schoser B, Lafor\u00eat P, Kruijshaar ME, et al. Minutes of the European Pompe consortium (EPOC) meeting March 27 to 28, 2015, Munich, Germany. Acta Myol. 2015;34:141\u20133.","journal-title":"Acta Myol"},{"key":"926_CR23","first-page":"78","volume":"32","author":"A Toscano","year":"2013","unstructured":"Toscano A, Montagnese F, Musumeci O. Early is better? A new algorithm for early diagnosis in late onset Pompe disease (LOPD). Acta Myol. 2013;32:78\u201381.","journal-title":"Acta Myol"},{"key":"926_CR24","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.ymgme.2009.08.003","volume":"99","author":"PS Kishnani","year":"2010","unstructured":"Kishnani PS, Goldenberg PC, DeArmey SL, et al. Cross-reactive immunologic material status affects treatment outcomes in Pompe disease infants. Mol Genet Metab. 2010;99:26\u201333. \n                    https:\/\/doi.org\/10.1016\/j.ymgme.2009.08.003\n                    \n                  .","journal-title":"Mol Genet Metab"},{"key":"926_CR25","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.jpeds.2014.10.068","volume":"166","author":"YH Chien","year":"2015","unstructured":"Chien YH, Lee NC, Chen CA, et al. Long-term prognosis of patients with infantile-onset Pompe disease diagnosed by newborn screening and treated since birth. J Pediatr. 2015;166:985\u201391. \n                    https:\/\/doi.org\/10.1016\/j.jpeds.2014.10.068\n                    \n                  .","journal-title":"J Pediatr"},{"key":"926_CR26","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.jpeds.2013.03.002","volume":"163","author":"ME Elder","year":"2013","unstructured":"Elder ME, Nayak S, Collins SW, et al. B-cell depletion and immunomodulation before initiation of enzyme replacement therapy blocks the immune response to acid alpha-glucosidase in infantile-onset Pompe disease. J Pediatr. 2013;163:847\u201354. \n                    https:\/\/doi.org\/10.1016\/j.jpeds.2013.03.002\n                    \n                  .","journal-title":"J Pediatr"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-019-00926-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12325-019-00926-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-019-00926-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,15]],"date-time":"2020-03-15T00:04:39Z","timestamp":1584230679000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12325-019-00926-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,16]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["926"],"URL":"https:\/\/doi.org\/10.1007\/s12325-019-00926-5","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,16]]},"assertion":[{"value":"19 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2019","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}